Incyte Corporation

Graft versus host disease

Oct 18, 2019

Incyte Corporation submits positive results of trials for its drug Ruxolitinib in GvHD

cholangiocarcinoma

Feb 22, 2019

What is Cholangiocarcinoma (CCA)?

Oct 17, 2016

JAK Inhibitors: New Lifeline for Hair Loss Treatment

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper